A Comparative Study of the Diagnostic and Prognostic Value of Squamous Cell Carcinoma Antigen and Alfa-foeto Protien in Hepatocellular Carcinoma Before and After Therapeutic Intervention
Sakty, T., Radwan, H., Maaty, M., Allam, A., Abd El Hamid, R., Yousef, M. (2018). A Comparative Study of the Diagnostic and Prognostic Value of Squamous Cell Carcinoma Antigen and Alfa-foeto Protien in Hepatocellular Carcinoma Before and After Therapeutic Intervention. EKB Journal Management System, 72(11), 5652-5657. doi: 10.21608/ejhm.2018.11542
Tarek Maged Al Sakty; Hesham Hamdy Radwan; Mohamed El Gharib Abou El Maaty; Ahmed Samir Allam; Ramy Samir Abd El Hamid; Mohamed Gamal Yousef. "A Comparative Study of the Diagnostic and Prognostic Value of Squamous Cell Carcinoma Antigen and Alfa-foeto Protien in Hepatocellular Carcinoma Before and After Therapeutic Intervention". EKB Journal Management System, 72, 11, 2018, 5652-5657. doi: 10.21608/ejhm.2018.11542
Sakty, T., Radwan, H., Maaty, M., Allam, A., Abd El Hamid, R., Yousef, M. (2018). 'A Comparative Study of the Diagnostic and Prognostic Value of Squamous Cell Carcinoma Antigen and Alfa-foeto Protien in Hepatocellular Carcinoma Before and After Therapeutic Intervention', EKB Journal Management System, 72(11), pp. 5652-5657. doi: 10.21608/ejhm.2018.11542
Sakty, T., Radwan, H., Maaty, M., Allam, A., Abd El Hamid, R., Yousef, M. A Comparative Study of the Diagnostic and Prognostic Value of Squamous Cell Carcinoma Antigen and Alfa-foeto Protien in Hepatocellular Carcinoma Before and After Therapeutic Intervention. EKB Journal Management System, 2018; 72(11): 5652-5657. doi: 10.21608/ejhm.2018.11542

A Comparative Study of the Diagnostic and Prognostic Value of Squamous Cell Carcinoma Antigen and Alfa-foeto Protien in Hepatocellular Carcinoma Before and After Therapeutic Intervention

The Egyptian Journal of Hospital Medicine
Article 23, Volume 72, Issue 11, July 2018, Page 5652-5657  XML PDF (281.4 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2018.11542
View on SCiNiTO View on SCiNiTO
Authors
Tarek Maged Al Sakty1; Hesham Hamdy Radwan1; Mohamed El Gharib Abou El Maaty2; Ahmed Samir Allam1; Ramy Samir Abd El Hamid; Mohamed Gamal Yousef email 3
1Internal Medicine Department, Faculty of Medicine, Ain Shams University
2Radiology Department, Faculty of Medicine, Ain Shams University
3Internal Medicine Department, Faculty of Medicine, Ain Shams University,
Abstract
Background: hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and it is one of the major causes of death, because of its high frequency and poor prognosis. Hepatocellular carcinoma is now a common malignancy in Egypt which usually develops on top of liver cirrhosis secondary to viral infection, as hepatitis C viruses increased the risk of HCC in the Egyptian patients. Aim of the Work: was to verify the possibility of using the plasma squamous cell carcinoma antigen level as a tumor marker for hepatocellular carcinoma and to evaluate its prognostic value in management of HCC. Patients and Methods: the study included 60 subjects divided into three groups: group I was 30 patients with hepatocellular carcinomas, group II was 15 patients with liver cirrhosis and group III was 15 normal subjects serving as a control group. Results: the plasma SCCA level was significantly higher in group I patients (with HCC), than in the group II patients (cirrhosis) and control group. SCCA showed direct significant correlation with the most of laboratory data specially AST, INR, number and size of lesion. Conclusion: plasma SCCA is a sensitive and specific serum marker for the diagnosis of HCC and combination of AFP and SCCA in screening and diagnosis of HCC yielded a better sensitivity in diagnosis of HCC.
Keywords
Squamous Cell Antigen; Alfa-foeto Protien; Hepatocellular carcinoma; Therapeutic Intervention
Statistics
Article View: 160
PDF Download: 362